酶疗法的挑战:为什么两个玩家比一个更好?
Sabrina Cuoghi1, Riccardo Caraffi1,2, Alessandro Anderlini1
1Nanotech Lab, Te.Far.T.I., Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.
概括
酶疗法面临挑战,但纳米平台可以增强酶药物. 在纳米载体中将酶与其他疗法结合起来,为复杂疾病提供了协同效应.
科学领域:
- 纳米医学是一种纳米医学.
- 酶疗法 酶疗法 酶疗法
- 药物输送系统 药物输送系统
背景情况:
- 基于酶的疗法具有很高的选择性和特异性,但由于其不良的物理化学和药理性质而受到限制.
- 酶降解,活性丧失,非目标积累和免疫性阻碍治疗疗效.
- 纳米平台可以封装酶来克服这些局限性,改善生物可用性和治疗结果.
研究的目的:
- 探索基于纳米医学的酶疗法对具有挑战性的疾病的潜力.
- 在单个纳米载体中研究将酶与其他治疗剂结合在一起的好处.
- 突出多元组件疗法的协同作用潜力,包括基因疗法应用.
主要方法:
- 在纳米平台中封装酶以提高稳定性和传递性.
- 开发单个纳米载体,共同提供酶和其他治疗剂 (小分子,蛋白质,核酸).
- 探索用于协同基因疗法的联合酶和核酸策略.
主要成果:
- 纳米颗粒封装减轻了酶降解,增强了活性,并降低了免疫性.
- 联合输送系统确保多种治疗药物在目标部位的同时到达和作用.
- 多元组件纳米药物显示出协同治疗效果和提高疗效的潜力.
结论:
- 纳米平台提供了一种可行的策略,以克服酶疗法的局限性.
- 综合纳米医学将酶与其他药物结合在一起,为协同疗法提供了一种强大的方法.
- 这一策略对治疗复杂疾病,包括神经和瘤疾病,以及推进基因治疗具有重大前景.
相关概念视频
Enzymes
81.4K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
81.4K
Introduction to Enzymes
17.5K
The use of enzymes by humans dates to 7000 BCE. Humans first used enzymes to ferment sugars and produce alcohol without knowing that this was an enzyme-catalyzed reaction. Wilhelm Kuhne coined the term 'enzyme' in 1877 from the Greek words ‘en’ meaning ‘in’ or ‘within’ and ‘zyme’ meaning ‘yeast.’
Most enzymes are proteins that speed up biochemical reactions without being consumed. Enzymes contain one or more active sites that...
Most enzymes are proteins that speed up biochemical reactions without being consumed. Enzymes contain one or more active sites that...
17.5K
Enzyme Inhibition
78.2K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.2K
Catalytically Perfect Enzymes
4.0K
The theory of catalytically perfect enzymes was first proposed by W.J. Albery and J. R. Knowles in 1976. These enzymes catalyze biochemical reactions at high-speed. Their catalytic efficiency values range from 108-109 M-1s-1. These enzymes are also called 'diffusion-controlled' as the only rate-limiting step in the catalysis is that of the substrate diffusion into the active site. Examples include triose phosphate isomerase, fumarase, and superoxide dismutase.
Most enzymes...
Most enzymes...
4.0K
Introduction to Mechanisms of Enzyme Catalysis
8.1K
For many years, scientists thought that enzyme-substrate binding took place in a simple "lock-and-key" fashion. This model stated that the enzyme and substrate fit together perfectly in one instantaneous step. However, current research supports a more refined view scientists call induced fit. The induced-fit model expands upon the lock-and-key model by describing a more dynamic interaction between enzyme and substrate. As the enzyme and substrate come together, their interaction causes...
8.1K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


